Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gennarelli

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesisChristoph Anacker, Annamaria Cattaneo, Ksenia Musaelyan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 24, 2025
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical settingAlessandra Minelli, Stefano Barlati, Stefano Bignotti, et al.
Neurogenetics|April 9, 2008
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical seriesBarbara Borroni, Silvana Archetti, Antonella Alberici, et al.
Neurobiology of Aging|August 21, 2003
Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patientsDavide Seripa, Gloria Dal Forno, Maria G Matera, et al.
Brain Sciences|May 27, 2026
Investigating Treatment Response in Obsessive-Compulsive Disorder Through Neuromodulation and Patient-Derived Induced Pluripotent Stem Cell Models: Preliminary Clinical Observations from a Translational StudyBeatrice Benatti, Matteo Marcatili, Rodolfo Leuzzi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 19, 2021
Evidence of an interaction between <i>FXR1</i> and <i>GSK3β</i> polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychoticsAntonio Rampino, Silvia Torretta, Barbara Gelao, et al.
Trials|December 13, 2021
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)Alessandra Minelli, Stefano Barlati, Erika Vitali, et al.
Annals of Neurology|December 19, 2003
Atypical dementia associated with a novel presenilin-2 mutationGiuliano Binetti, Simona Signorini, Rosanna Squitti, et al.
Scientific Reports|April 18, 2023
Author Correction: Assessment of haptoglobin alleles in autism spectrum disordersFrancesca Anna Cupaioli, Ettore Mosca, Chiara Magri, et al.
Journal of Psychiatric Research|June 6, 2026
Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trialMaria Luca, Alessandro Serretti, Stefano Barlati, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesisChristoph Anacker, Annamaria Cattaneo, Ksenia Musaelyan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 24, 2025
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical settingAlessandra Minelli, Stefano Barlati, Stefano Bignotti, et al.
Neurogenetics|April 9, 2008
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical seriesBarbara Borroni, Silvana Archetti, Antonella Alberici, et al.
Neurobiology of Aging|August 21, 2003
Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patientsDavide Seripa, Gloria Dal Forno, Maria G Matera, et al.
Brain Sciences|May 27, 2026
Investigating Treatment Response in Obsessive-Compulsive Disorder Through Neuromodulation and Patient-Derived Induced Pluripotent Stem Cell Models: Preliminary Clinical Observations from a Translational StudyBeatrice Benatti, Matteo Marcatili, Rodolfo Leuzzi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 19, 2021
Evidence of an interaction between <i>FXR1</i> and <i>GSK3β</i> polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychoticsAntonio Rampino, Silvia Torretta, Barbara Gelao, et al.
Trials|December 13, 2021
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)Alessandra Minelli, Stefano Barlati, Erika Vitali, et al.
Annals of Neurology|December 19, 2003
Atypical dementia associated with a novel presenilin-2 mutationGiuliano Binetti, Simona Signorini, Rosanna Squitti, et al.
Scientific Reports|April 18, 2023
Author Correction: Assessment of haptoglobin alleles in autism spectrum disordersFrancesca Anna Cupaioli, Ettore Mosca, Chiara Magri, et al.
Journal of Psychiatric Research|June 6, 2026
Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trialMaria Luca, Alessandro Serretti, Stefano Barlati, et al.
Pageof 22